Changing Management of Hematological Malignancies With COVID-19: Statement and Recommendations of the Lebanese Society of Hematology and Blood Transfusion.

Ibrahim, Ahmad; Noun, Peter; Khalil, Charbel; Taher, Ali

Ibrahim, Ahmad; Noun, Peter; Khalil, Charbel; Taher, Ali.

Afiliação

Ibrahim A; Division of Hematology-Oncology, Department of Medicine, Lebanese and Arab Universities, Beirut, Lebanon.
Noun P; Cancer Center and Bone Marrow Transplantation (BMT) Program at Middle East Institute of Health, Bsalim, Lebanon.
Khalil C; Bone Marrow Transplantation (BMT) Program at Makassed University Hospital, Beirut, Lebanon.
Taher A; Lebanese Society of Hematology and Blood Transfusion, Beirut, Lebanon.

Front Oncol ; 11: 564383, 2021.

Article em En | MEDLINE | ID: mdl-33791197

Palavras-chave

LSHBT; SARS-Cov-2 infection; hematological malignancies; lymphoid; myeloid

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article